A polyclonal rabbit antibody to a peptide derived from the N-terminus of human DNMT1.
| Institute |
|---|
| Johns Hopkins University |
| Cat. #: | 156434 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Genetics |
| Application: | IHC |
| Target: | DNMT1 |
| Class: | Polyclonal |
| Product description: | A polyclonal rabbit antibody to a peptide derived from the N-terminus of human DNMT1. A sub-contractor was provided with the peptide sequence, synthesized the peptide, injected rabbits, and collected the immune sera. The antibodies were characterized and showed usefulness in detecting human DNMT1 by immunoblot and by immunohistochemistry |
|---|---|
| Conjugation: | Unconjugated |
| Target background: | A polyclonal rabbit antibody to a peptide derived from the N-terminus of human DNMT1. A sub-contractor was provided with the peptide sequence, synthesized the peptide, injected rabbits, and collected the immune sera. The antibodies were characterized and showed usefulness in detecting human DNMT1 by immunoblot and by immunohistochemistry |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
De Marzo et al. 1999. Cancer Res. 59(16):3855-60. PMID: 10463569. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.